Skip to content
  • Friday, 14 August 2026
  • 10:19 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities
Pharmaceutical R&D

Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities

Teuku Ryan Jul 21, 2026 0

Samsung Biologics has announced its intent to acquire PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specializing in…

Read More
Stem Cell & Regenerative Medicine

Bioengineered Bone Marrow-on-a-Chip Platform Replicates Human Immune Response and Advances Drug Development Capabilities

Dwi Wanna Jul 16, 2026 0

The human skeletal system serves as more than just a structural framework; deep within the cavities of our bones lies…

Read More
Neuroscience & Brain Research

Unconscious Brain Activity During General Anesthesia Reveals Sophisticated Language Processing and Predictive Capabilities in the Hippocampus

Rifan Muazin Jul 1, 2026 0

The traditional understanding of general anesthesia as a state of total cognitive "shutdown" has been fundamentally challenged by a landmark…

Read More
Data Science & Bioinformatics

The Rise of Compact Powerhouses: 5 Small Language Models Redefining Agentic AI with Advanced Tool Calling Capabilities

Evan Lee Salim May 14, 2026 0

Agentic AI systems, designed to intelligently perform complex tasks by autonomously selecting and utilizing various digital tools, are fundamentally reliant…

Read More
Pharmaceutical R&D

The Surge in Oncology Innovation Fuels Strategic Investment in HPAPI and ADC Manufacturing Capabilities

Teuku Ryan Apr 30, 2026 0

The accelerating demand for highly potent active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs) is compelling contract development and manufacturing…

Read More
Pharmaceutical R&D

Merck KGaA Acquires JSR Life Sciences’ Chromatography Business to Bolster Biopharmaceutical Purification Capabilities

Teuku Ryan Apr 3, 2026 0

Germany-based Merck KGaA, a leading science and technology company, has officially completed its previously announced acquisition of the chromatography business…

Read More
Machine Learning Framework Unveils Hidden Physical Laws of Non-Reciprocal Forces in Complex Dusty Plasma SystemsPharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.Crossword: Traveling LightScience News: A Century of Empowering Public Understanding of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ